Weight Loss and Aggression
Evaluation of the Relationship Between Weight Loss and Aggression After Laparoscopic Sleeve Gastrectomy Surgery
1 other identifier
observational
50
1 country
1
Brief Summary
Obesity has become an important medical and social problem in western countries today. Although many surgical procedures are performed for obesity, Laparoscopic sleeve gastrectomy (LSG) has become the most common bariatric procedure in obesity. The absence of digestive anastomosis, the absence of mesenteric defects that may cause internal hernias and foreign materials such as gastric band are among the advantages of this surgical method. Obesity is a complex multifactorial disease. Obesity is not a mental disorder, but is associated with serious serious conditions and increases the risk of mental disorders. The social label of obesity will have long-lasting devastating effects on mental health. In addition, obesity is associated with undesirable conditions; Misperception of dietary needs, self-perceived health status and potential social isolation, negative attitude towards appearance, aggression, depression, anxiety, attention deficit/hyperactivity disorder, behavioral problem, and bullying are some of the problems associated with obesity. Body changes are important in the experience of being different from their peers and can result in lowered self-esteem and be a barrier to social functioning. Studies on this condition have shown that obese subjects have poor social functioning and social skills. There are many factors that cause aggression, but obesity is one of them. Although there are many studies examining the relationship between overweight and aggression in children and adolescent patient groups, studies examining the adult patient group are limited. Starting from this point, we aimed to determine the change in aggression after weight loss in patients who underwent LSG surgery in the study we created.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2022
CompletedStudy Start
First participant enrolled
December 15, 2022
CompletedFirst Posted
Study publicly available on registry
December 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2024
CompletedDecember 16, 2022
December 1, 2022
1 year
December 8, 2022
December 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
agression score after weight loss
After significant weight loss in the first year after laparoscopic sleeve gastrectomy, the preoperative aggression questionnaires will be re-administered to all patients.
1 year
Secondary Outcomes (1)
agression score before weight loss
1 year
Study Arms (2)
agression before surgery
The group that the aggression assessment when morbidly obese before surgery
agression after surgery
group reassessed for aggression following postoperative weight loss
Interventions
Laparoscopic sleeve gastrectomy surgery will be performed by a single surgeon.
Eligibility Criteria
All patients undergoing laparoscopic sleeve gastrectomy were included in the study. It was planned to investigate the changes in aggression rates before and after weight loss by applying aggression questionnaires to all patients.
You may qualify if:
- years and older and younger than 64 years old.
- At least 5 years of morbid obesity (BMI \>40 or \>35 comorbidity)
- Patients with temporary or inadequate response (less than 10% of body weight will be considered insufficient) weight loss despite diet for at least 6 months before the operation under the guidance of a dietitian.
You may not qualify if:
- Past upper gastrointestinal surgery,
- Paraesophageal (type 2), mixed (type 3), or sliding hiatal hernias of 3 cm or more,
- Patients with esophagitis and/or Barrett's metaplasia in upper gastrointestinal system (GIS) endoscopy
- Those with peripheral vascular disease Those with a history of cerebrovascular accident
- Patients with coagulopathy
- History of chronic analgesic use
- Patients with perioperative complications
- Patients with a previous psychiatric diagnosis other than depression
- Patients who lost less than 10% of their initial weight at the 6th month after the operation
- patients with chronic alcohol use
- patients with recent psychological trauma
- low-income patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatih Sultan Mehmet Research and Training Hospital
Istanbul, 34734, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Uzman Doktor
Study Record Dates
First Submitted
December 8, 2022
First Posted
December 16, 2022
Study Start
December 15, 2022
Primary Completion
December 15, 2023
Study Completion
February 15, 2024
Last Updated
December 16, 2022
Record last verified: 2022-12